February 14, 2019
The HDA Research Foundation today announced the selection of four HDA-member professionals as the inaugural recipients of its graduate-level scholarship program.
Healthcare Distribution Alliance – Patients Move Us.
SEARCH
News
FEATURED NEWS
Sean Spears of Eisai Honored With 2021 Nexus Award for Lifetime Achievement
November 17, 2021
The HDA Research Foundation recognized Sean Spears of Eisai, Inc., with the 2021 Nexus Award for Lifetime Achievement last night at the Thirteenth Annual CEO Roundtable Fundraiser in Washington, D.C. The...
HDA Statement on FDA Commissioner Nominee Dr. Robert Califf
November 12, 2021
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding President Biden’s nomination of Dr. Robert Califf as FDA Commissioner.
HDA Foundation Survey Reveals Uneven Progress on Rx Product Serialization, with 2023 DSCSA Requirements Around the Corner
November 1, 2021
The pharmaceutical supply chain’s progress on implementing product serialization requirements to comply with the Drug Supply Chain Security Act (DSCSA) has slowed as the November 2023 deadline for compliance...
Results: 173 Articles found.
-
HDA Research Foundation Announces Inaugural Scholarship Recipients
-
AAOA Celebrates First Year of Working with Partners to Address the Opioid Epidemic Through EducationFebruary 13, 2019
This month marks one year since the launch of Allied Against Opioid Abuse (AAOA), a national initiative to help address the nation’s prescription opioid abuse epidemic through education and awareness. In its first year, AAOA built a network of national and local partnerships, expanding its membership to include 16 national partners and more than 50 state and local partners.
-
HDA Statement on New York Opioid Stewardship Act RulingDecember 19, 2018
Following U.S. District Court Judge Katherine Polk Failla’s ruling today that New York’s Opioid Stewardship Act is unconstitutional, the Healthcare Distribution Alliance (HDA) issued the following statement.
-
HDA Statement on Energy and Commerce Committee Report Regarding Opioid Distribution in West VirginiaDecember 19, 2018
On the release of the Energy and Commerce Committee’s review of opioid distribution in West Virginia, the Healthcare Distribution Alliance (HDA) released the following statement.
-
HDA Research Foundation Specialty Pharmaceutical Analysis Highlights Distributor Efficiencies Amid Evolving Market DynamicsDecember 18, 2018
Data published by the HDA Research Foundation reveal the changing market dynamics of the nearly $200 billion specialty pharmaceutical supply chain segment — and the important role HDA-member specialty pharmaceutical distributors play within it. The 2018 Specialty Pharmaceutical Distribution: Facts, Figures and Trends publication is based on an annual survey of HDA-member specialty distributors with sales greater than $1 billion for the 2017 (or most recently completed) fiscal year, and includes secondary data from leading healthcare organizations, such as IQVIA.
Media Contacts
